SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - 1) Approval Of Audited Standalone And Consolidated Financial Statements For The Quarter And Year Ended March 31, 2021. 2) Recommendation Of Payment Of Final Dividend For The Financial Year Ended March 31, 2021.
As per letter attached27-05-2021